The Efficacy and Safety of Liraglutide on Body Weight Loss in Obese and Overweight Patients

Summary

This is a multicenter, randomized, double-blind, placebo controlled trial to evaluate the effect and safety of Liraglutide Injection on body weight loss compared with placebo in obese or overweight adult patients with comorbidity of metabolic disorders.

Timeline

Start

2020-08-18

Primary completion

2022-12-31

Completion

2023-04-15

Drugs

Indications